NKX6-1 and type 2 diabetes mellitus: Our study provides evidence that NKX6.1 is downregulated in pancreatic islets from T2D donors and, more importantly, that it regulates miR-184-3p expression in both human and mouse β-cells by specifically binding to DRE present in its proximal promoter.